Eli Lilly takes aim at illicit market for its experimental weight-loss drug
Automated news aggregation. Headlines and summaries are gathered from public feeds; see our editorial standards for sourcing, corrections, and AI-assist disclosure.
Related coverage: Eli Lilly takes aim at illicit market for its experimental weight-loss drug CBS News Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide CNBC Eli Lilly Sues Sellers of Black Market Weight-Loss Drugs WSJ Eli Lilly sues 6 companies over illegal retatrutide sales qz.com Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market Eli Lilly and Company
About this story
This story was aggregated from CBS News. Headlines, summaries, and links are gathered automatically from public RSS feeds for your convenience.
Read the full story →For agents:JSON recordOpenAPIWebMCPllms.txt